Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

NCT00604760 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Cognitive Impairment Associated With Schizophrenia

Interventions

DRUG: MEM 3454
DRUG: MEM 3454
DRUG: MEM 3454
DRUG: Placebo for MEM 3454

Sponsor

Memory Pharmaceuticals